Gene · 4841
NIH grants1,250
NIH grants whose papers are about the gene, through NIH's grant-paper links.
181 to 200 of 1,250
Download this page as JSON| Grant | Title | NONO papers | Newest fiscal year |
|---|---|---|---|
| R35GM122597 | RNA and Genomic Junk in Fundamental Chromosome Architecture and Regulation | 1 | 2025 |
| R35GM124896 | Functional Dissection of Metabolic-Sensing Proline Hydroxylation Pathways | 1 | 2025 |
| R35GM124974 | Mirror Image Aptamers: Next Generation RNA-Binding Reagents for Basic Research and Therapeutic Applications | 1 | 2025 |
| R35GM127303 | Understanding and Manipulating G Protein α Subunit and Phospholipase C Signaling Networks | 1 | 2025 |
| R35GM128786 | Signal Integration from Membranes to the Actin Cytoskeleton | 1 | 2025 |
| R35GM131780 | Protein-nucleic acid interactions in basic cellular processes | 1 | 2025 |
| R35GM133425 | Design principles and dynamic gene control in embryonic development | 1 | 2025 |
| R35GM133552 | Coordination of chaperone interactions that dictate protein folding and trafficking | 1 | 2025 |
| R35GM134947 | Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging | 1 | 2025 |
| R35GM138035 | Regulation of rRNA transcription in mammalian tissues | 1 | 2025 |
| R35GM142637 | Spatiotemporal tools to interrogate O-GlcNAc functions in cellular signaling | 1 | 2025 |
| R37AI042999 | Pattern Recognition Receptors and Autophagy in Mtb Control in AIDS | 1 | 2025 |
| R37CA263622 | The Prognostic Significance and Mechanistic Determination of Chromatin Remodeling Biomarkers in Non-Functional Pancreatic Neuroendocrine Tumor | 1 | 2025 |
| RM1GM139738 | Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function | 1 | 2025 |
| RM1HG009490 | Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease | 1 | 2025 |
| T32AG052375 | Stroke and Alzheimers Disease Related Dementias | 1 | 2025 |
| T32AG058524 | Vanderbilt Interdisciplinary Training Program in Alzheimer's Disease | 1 | 2025 |
| T32CA009110 | Training in Areas Fundamental to Cancer Research | 1 | 2025 |
| T32CA009172 | Physician Scientist Training in Cancer Research | 1 | 2025 |
| T32CA009216 | Molecular Immunology and Tumor Biology | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/grants?page=10